Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy
PHASE3CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
June 30, 2001
Primary Completion Date
November 30, 2004
Study Completion Date
November 30, 2004
Conditions
Sarcoma
Interventions
DRUG
rhTPO
Trial Locations (1)
77030
UT MD Anderson Cancer Center, Houston
All Listed Sponsors
lead
M.D. Anderson Cancer Center
OTHER
NCT00283582 - Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy | Biotech Hunter | Biotech Hunter